Clinical Trials Logo

Clinical Trial Summary

To characterize the pharmacokinetics (PK) of naloxegol after single oral dose and through population PK in paediatric patients with opioid induced constipation (OIC) or at risk of OIC.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02099591
Study type Interventional
Source Kyowa Kirin Co., Ltd.
Contact
Status Completed
Phase Phase 1
Start date November 2014
Completion date April 2021